Dr. Barry Dworkin

In vitro studies reported in NEJM show that Pfizer/Moderna vaccines were still able to neutralize variant B.1.351 from South Africa despite reduction in neutralizing antibodies. Authors’ opinion is that vaccine remains efficacious. More to follow.

Medical Mythbusting Commentary for February 18, 2021

Source:
Pfizer says South African variant could notably cut down vaccine protection

Reference:
Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report

Related posts:

  1. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  2. Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.
  3. Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.
  4. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.